ABVC BIOPHARMA, INC. Quarterly Operating Margin in % from Q3 2011 to Q3 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Abvc Biopharma, Inc. quarterly/annual Operating Margin history and growth rate from Q3 2011 to Q3 2024.
  • Abvc Biopharma, Inc. Operating Margin for the quarter ending September 30, 2024 was -1.24K %, a 2.18% increase year-over-year.
  • Abvc Biopharma, Inc. annual Operating Margin for 2023 was -5.39K %, a 246% decline from 2022.
  • Abvc Biopharma, Inc. annual Operating Margin for 2022 was -1.56K %, a 52.6% increase from 2021.
  • Abvc Biopharma, Inc. annual Operating Margin for 2021 was -3.29K %, a 86.8% decline from 2020.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -1.24K +27.7 +2.18% Jul 1, 2024 Sep 30, 2024
Q2 2024 -6.26K -4.83K -338% Apr 1, 2024 Jun 30, 2024
Q1 2024 -38.5K -37.5K -3718% Jan 1, 2024 Mar 31, 2024
Q4 2023 -5.39K -3.83K -246% Oct 1, 2023 Dec 31, 2023
Q3 2023 -1.27K +4.1K +76.4% Jul 1, 2023 Sep 30, 2023
Q2 2023 -1.43K +2.74K +65.7% Apr 1, 2023 Jun 30, 2023
Q1 2023 -1.01K +13.1K +92.9% Jan 1, 2023 Mar 31, 2023
Q4 2022 -1.56K +1.73K +52.6% Oct 1, 2022 Dec 31, 2022
Q3 2022 -5.37K -3.15K -142% Jul 1, 2022 Sep 30, 2022
Q2 2022 -4.17K -2.18K -109% Apr 1, 2022 Jun 30, 2022
Q1 2022 -14.1K -12.8K -995% Jan 1, 2022 Mar 31, 2022
Q4 2021 -3.29K -1.53K -86.8% Oct 1, 2021 Dec 31, 2021
Q3 2021 -2.22K -1.3K -142% Jul 1, 2021 Sep 30, 2021
Q2 2021 -2K -1.23K -161% Apr 1, 2021 Jun 30, 2021
Q1 2021 -1.29K -600 -87.5% Jan 1, 2021 Mar 31, 2021
Q4 2020 -1.76K -1.27K -257% Oct 1, 2020 Dec 31, 2020
Q3 2020 -918 Jul 1, 2020 Sep 30, 2020
Q2 2020 -764 Apr 1, 2020 Jun 30, 2020
Q1 2020 -686 Jan 1, 2020 Mar 31, 2020
Q4 2019 -493 Oct 1, 2019 Dec 31, 2019
Q3 2015 -40.1K Jul 21, 2015 Sep 30, 2015
Q4 2013 -5.23K* +2.45K Oct 1, 2013 Dec 31, 2013
Q3 2013 -2.28K +17.7K +88.6% Jul 1, 2013 Sep 30, 2013
Q2 2013 -3.66K +21.8K +85.6% Apr 1, 2013 Jun 30, 2013
Q1 2013 -6.57K +28.1K +81.1% Jan 1, 2013 Mar 31, 2013
Q4 2012 -7.68K +63.8K +89.2% Oct 1, 2012 Dec 31, 2012
Q3 2012 -20K +39.2K +66.2% Jul 1, 2012 Sep 30, 2012
Q2 2012 -25.4K Apr 1, 2012 Jun 30, 2012
Q1 2012 -34.7K Jan 1, 2012 Mar 31, 2012
Q4 2011 -71.5K Oct 1, 2011 Dec 31, 2011
Q3 2011 -59.2K Jul 1, 2011 Sep 30, 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.